Skip to content

Delirium, Agitation/Sedation, Pain and Dyspnea in Respiratory Intensive Care Unit (NIVILIUM)

Longitudinal Assessment of Delirium, Agitation/Sedation, Pain and Dyspnea in Patients Admitted to Respiratory Intensive Care Unit for Acute Respiratory Failure (NIVILIUM)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03880084
Acronym
NIVILIUM
Enrollment
92
Registered
2019-03-19
Start date
2019-08-01
Completion date
2025-01-01
Last updated
2023-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Agitation,Psychomotor, Delirium, Dyspnea, Mechanical Ventilation Complication, Pain, Respiratory Failure

Brief summary

Non-Invasive Mechanical Ventilation (NIV) has been increasingly used in the treatment of acute respiratory failure. Notwithstanding failure rates still remains high, ranging from 5% to 60%. The onset of delirium, agitation, pain and dyspnea may contribute to reduce the success rate of non invasive ventilation treatment. The aim of this study is to assess the incidence and impact of delirium, agitation, pain and dyspnea on clinical outcomes in a population of patient admitted to Respiratory Intensive Care Unit undergoing Non-Invasive Mechanical Ventilation for Acute Respiratory Failure.

Interventions

OTHERObservation

To systematically assess the onset of delirium, quantify the level of agitation/sedation, estimate the grade of pain and survey the level of dyspnea in patients undergoing non invasive mechanical ventilation

Sponsors

University of Modena and Reggio Emilia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* patients with acute respiratory failure admitted to the Respiratory Intensive Care Unit of the University Hospital of Modena undergoing non invasive mechanical ventilation

Exclusion criteria

* age lower than 18 * Glasgow Coma Scale lower than 10 within 24 hours from Respiratory Intensive Care Unit admission * need for immediate orotracheal intubation * pregnancy * previously established psychiatric disease or dementia

Design outcomes

Primary

MeasureTime frameDescription
Incidence of dyspnea7 days from Respiratory Intensive Care Unit admissionThe onset of delirium will be assessed through the Borg scale, ranges 0-10, values \> 0 indicate the presence of dyspnea
Incidence of delirium7 days from Respiratory Intensive Care Unit admissionThe onset of delirium will be assessed through the Confusion Assessment Method for Intensive Care Unit 7 scale, ranges 0-7, values \> 2 indicate the presence of delirium
Incidence of agitation7 days from Respiratory Intensive Care Unit admissionThe onset of delirium will be assessed through the Richmond Agitation Sedation Scale ranges +4 to -5, values \> 0 indicate the presence of agitation, values \< 0 indicate the presence of sedation
Incidence of pain7 days from Respiratory Intensive Care Unit admissionThe onset of delirium will be assessed through the Behavioral Pain Scale, ranges 3-12, values \> 4 indicate the presence of pain

Secondary

MeasureTime frameDescription
The impact of delirium on Non Invasive Ventilation Success30 days from Respiratory Intensive Care Unit admissionThe correlation between the onset of delirium and the failure rates of Non Invasive Ventilation Treatment will be assessed
The impact of agitation on Non Invasive Ventilation Success30 days from Respiratory Intensive Care Unit admissionThe correlation between the onset of agitation and the failure rates of Non Invasive Ventilation Treatment will be assessed
The impact of pain on Non Invasive Ventilation Success30 days from Respiratory Intensive Care Unit admissionThe correlation between the onset and level of pain and the failure rates of Non Invasive Ventilation Treatment will be assessed
The impact of dyspnea on Non Invasive Ventilation Success30 days from Respiratory Intensive Care Unit admissionThe correlation between the onset and level of dyspnea and the failure rates of Non Invasive Ventilation Treatment will be assessed

Countries

Italy

Contacts

Primary ContactAlessandro Marchioni, MD
marchioni.alessandro@unimore.it00390594225859

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026